Rubi Khaw Li, MD – FDA Inspection, Jan 16, 2026

Record Details

This FDA Inspection record concerns Rubi Khaw Li, MD, with an inspection on January 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Rubi Khaw Li, MD
Inspection Date: January 16, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Dina A. Tallman (Company Rep)

View Company Profile

ID · 58f5fe39-0f4d-4a16-bd8d-64fb0efc4909

Inspection Facts

Inspection number: 1298584
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rubi Khaw Li, MD

FDA Inspection

Rubi Khaw Li, MDJanuary 16, 2026

Rubi Khaw Li, MD – FDA Inspection, Jan 16, 2026

Record Details

This FDA Inspection record concerns Rubi Khaw Li, MD, with an inspection on January 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.